Ven Bio Global Strategic Fund Iii, L.P. is > 10% Shareholder of Ventyx Biosciences, Inc.. Currently has a direct ownership of 4 Million shares of VTYX, which is worth approximately $8.67 Million. The most recent transaction as insider was on Oct 25, 2021, when has been sold 312,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $5,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4M
0% 3M change
0% 12M change
Total Value Held $8.67 Million

venBio Global Strategic Fund III, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 25 2021
BUY
Open market or private purchase
$5,000,000 $16.0 p/Share
312,500 Added 7.25%
3,997,269 Common Stock
Oct 25 2021
BUY
Conversion of derivative security
-
3,684,769 Added 50.0%
3,684,769 Common Stock

Also insider at

ELEV
Elevation Oncology, Inc. Healthcare
RYZB
RayzeBio, Inc.
RTVA
Artiva Biotherapeutics, Inc.
vGS

Ven Bio Global Strategic Fund Iii, L.P.

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on VTYX

Follow Ventyx Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTYX shares.

Notify only if

Insider Trading

Get notified when an Ventyx Biosciences, Inc. insider buys or sells VTYX shares.

Notify only if

News

Receive news related to Ventyx Biosciences, Inc.

Track Activities on VTYX